Further studies revealed that the transferrin receptor 1 was upregulated in response to such MYCN amplification, leading to increased GPx4 sensitivity and rendering neuroblastoma cells vulnerable to ferroptosis induction (20). The gene discussed is MYCN; the disease is neuroblastoma.